glp-1 and intermittent fasting Together Does Fasting Increase GLP-1: Exploring

The effect of gluten-free diet on thyroid autoimmunity in drug-nave women with Hashimotos thyroiditis: a pilot study

The oral segment is projected to witness the fastest CAGR from 2025 to 2032, driven by the growing demand for needle-free alternatives and the launch of oral GLP-1 receptor agonists such as Rybelsus (oral semaglutide) and future pipeline products such as orforglipron

doi: 10.1016/j.biopha.2018.08.088 93 Yildirim SimsirISoyaltinUECetinkalpS

But theyre also a reminder of what sustained investment in basic science can achieve. As UAB researchers continue to study how these drugs work and what comes next, their findings are helping move the conversation beyond hype, while working toward a clearer understanding of one of the most significant medical breakthroughs of the past decade.